Breakthrough CD19+ B-Cell Targeted Therapy Delivered an 87% Reduction in the Risk of Flares Versus Placebo UPLIZNA Shown to Deliver Corticosteroid-Free, Flare-Free, Complete Remission for Patients in the MITIGATE Trial Advances Amgen's Leadership in CD19 Directed, B-Cell Depletion...
Read More Details
Finally We wish PressBee provided you with enough information of ( UPLIZNA® (INEBILIZUMAB-CDON) IS NOW THE FIRST AND ONLY FDA-APPROVED TREATMENT FOR IGG4-RELATED DISEASE )
Also on site :
- Julia Fox's Net Worth in 2025 Proves She's an It Girl
- Israel strikes Syria again, claims to have killed alleged Hamas member
- Plane crashes at Tennessee Airport: Injuries recorded